Motta G, Esposito E, Motta S, Mansi N, Cappello V, Cassiano B, Motta G
Dipartimento di Otorinolaringoiatria dell'Azienda Universitaria "Federico II" di Napoli, FR.
Acta Otorhinolaryngol Ital. 2006 Oct;26(5 Suppl 84):5-29.
In paediatric patients, recurrent febrile pharyngo-tonsillitis is usually due to chronic inflammation of the tonsils and/or adenoids: these episodes are often associated with other clinical manifestations (respiratory obstruction of naso-pharyngeal origin; auricular inflammation, especially effusive otitis media and acute otitis media; streptococcal beta-haemolytic Group A (SBEGA) infection, causing a distant disorder of varying severity and which may, therefore, give rise to serious pathological conditions). A retrospective multicentric investigation has, therefore, been carried out in order not only to further elaborate findings emerging from earlier studies, performed in other countries, in which random methods were used, but also to focus on: 1. the possible association of these clinical manifestations with recurrent febrile pharyngo-tonsillar inflammation in relation to frequency of the condition; 2. results obtained with adenoidectomy or with adeno-tonsillectomy, referring to the overall clinical outcome of the pathological condition, bearing in mind data emerging from the control groups, submitted to strict follow-up, associated with any medical treatment deemed necessary.
The study population comprised 692 patients (394 male, 298 female), age range 2-11 years and with a minimum follow-up of 2 years. Considering the clinical manifestations emerging from the case history, the following two investigations were carried out: 1. the first, on 501 patients, all previously submitted to adeno-tonsillectomy in whom the recurrent febrile pharyngo-tonsillar inflammation had occurred, respectively > 4 or < or = 4 episodes during the last 12 months; 2. the second, on 455 patients in whom recurrent febrile pharyngo-tonsillar inflammation, in the 12 months prior to the beginning of the study, had been < or = 4 episodes: in 264 cases, adeno-tonsillectomy was carried out; in 144, adenoidectomy; 47 children were studied as controls and, therefore, submitted to watchful waiting. The results obtained were statistically analysed by chi2 and Fisher test: a "p" value of < 0.05 was considered statistically significant.
The first investigation showed that all symptomatological manifestations considered were resolved following adeno-tonsillectomy, in a significantly high percentage of cases (recurrent febrile pharyngo-tonsillar in flammation: 91.8%; naso-pharyngeal respiratory obstruction: 92.2%; pathological ASO titre: 69.8%; distant disorders probably due to SBEGA: 76%; effusive otitis media: 76%; acute recurrent otitis media: 87.5%). The most interesting clinical findings obtained can be summarized as follows: naso-pharyngeal respiratory obstruction is a frequent finding; the incidence is statistically higher in cases in which recurrent febrile pharyngo-tonsillar inflammation is less frequent (p < 0.05): in these patients, this is an important pathological manifestation indicating the need for surgery; the higher incidence is associated with at significant finding of pathological auricular processes; the percentages of recovery for naso-pharyngeal respiratory obstruction are statistically greater in the group of patients in whom the recurrent febrile pharyngo-tonsillar inflammation is more frequent: an identical result is found in patients with the effusive form of otitis media and in those with recurrent acute otitis media; a pathological ASO titre is more frequently found, the difference being statistically significant (p < 0.05), in the group of patients with more frequent recurrent febrile pharyngo-tonsillar inflammation, albeit this factor does not affect the percentage of recovery; also the favourable evolution and recovery of clinical distant manifestations, related to streptococcal beta-haemolytic Group A infection, are correlated with the return to normal of the ASO titre. The second investigation demonstrated the efficacy of surgical treatment, adeno-tonsillectomy and adenoidectomy, in all the clinical manifestations studied, the possibility of achieving resolution of recurrent febrile pharyngo-tonsillar inflammation even in the control subjects submitted to medical treatment, but also the lack of success, in the latter, as far as concerns naso-pharygeal respiratory obstruction, the pathological ASO titre and the inflammatory auricular processes.
The present investigations confirm previous observations emerging from randomized clinical studies, regarding the possibility to achieve valid prevention of recurrent febrile pharyngo-tonsillar inflammation, also in a large percentage of control patients submitted to watchful waiting; these investigations, however, also demonstrated that, in the control group, the percentage of subjects in whom recovery of other symptoms was achieved was very low compared to that in the groups submitted to surgery. In other words, clearly emerges as far as concerns the overall symptomatological picture of the patients, the efficacy of the surgical treatment, but also the lack of success of the medical treatments in all clinical manifestations associated with recurrent febrile inflammations. Therefore, it is necessary to select and advise the most suitable treatment strategy, not in relation to the Guidelines elaborated on the basis of results emerging from statistical research, that, due to the intrinsic methodology limits cannot be applied to all cases in an acritical fashion, but in relationship to the specific clinical picture of each individual patient.
在儿科患者中,复发性发热性咽扁桃体炎通常是由于扁桃体和/或腺样体的慢性炎症引起的:这些发作常伴有其他临床表现(鼻咽部起源的呼吸阻塞;耳部炎症,尤其是分泌性中耳炎和急性中耳炎;A 组β溶血性链球菌(SBEGA)感染,可导致不同严重程度的远处疾病,因此可能引发严重的病理状况)。因此,开展了一项回顾性多中心调查,目的不仅是进一步阐述在其他国家进行的早期研究中出现的结果,这些研究采用了随机方法,而且还要关注:1. 这些临床表现与复发性发热性咽扁桃体炎的可能关联,以及病情的频率;2. 腺样体切除术或腺样体扁桃体切除术的结果,参考病理状况的总体临床结果,同时考虑到对照组的数据,这些对照组经过严格随访,并接受了任何必要的药物治疗。
研究人群包括 692 名患者(男性 394 名,女性 298 名),年龄范围为 2 - 11 岁,最短随访时间为 2 年。根据病史中出现的临床表现,进行了以下两项调查:1. 第一项调查针对 501 名患者,他们之前均接受了腺样体扁桃体切除术,其中复发性发热性咽扁桃体炎在过去 12 个月内分别发生了>4 次或<或 = 4 次发作;2. 第二项调查针对 455 名患者,在研究开始前的 12 个月内,复发性发热性咽扁桃体炎发作次数<或 = 4 次:其中 264 例进行了腺样体扁桃体切除术;144 例进行了腺样体切除术;47 名儿童作为对照组,因此接受观察等待。通过 chi2 和 Fisher 检验对获得的结果进行统计学分析:“p”值<0.05 被认为具有统计学意义。
第一项调查显示,在接受腺样体扁桃体切除术后,所有考虑的症状表现均有显著高比例得到缓解(复发性发热性咽扁桃体炎:91.8%;鼻咽部呼吸阻塞:92.2%;病理性抗链球菌溶血素 O 滴度:69.8%;可能由 SBEGA 引起的远处疾病:76%;分泌性中耳炎:76%;复发性急性中耳炎:87.5%)。获得的最有趣的临床发现可总结如下:鼻咽部呼吸阻塞是常见表现;在复发性发热性咽扁桃体炎发作频率较低的病例中,其发生率在统计学上更高(p < 0.05):在这些患者中,这是表明需要手术的重要病理表现;较高的发生率与病理性耳部病变的显著发现相关;在复发性发热性咽扁桃体炎发作频率较高的患者组中,鼻咽部呼吸阻塞的恢复百分比在统计学上更高:分泌性中耳炎患者和复发性急性中耳炎患者也有相同结果;病理性抗链球菌溶血素 O 滴度在复发性发热性咽扁桃体炎发作频率较高的患者组中更常出现,差异具有统计学意义(p < 0.05),尽管该因素不影响恢复百分比;与 A 组β溶血性链球菌感染相关的临床远处表现的良好演变和恢复也与抗链球菌溶血素 O 滴度恢复正常相关。第二项调查证明了手术治疗(腺样体扁桃体切除术和腺样体切除术)在所有研究的临床表现中的有效性,即使在接受药物治疗的对照组中也有可能实现复发性发热性咽扁桃体炎的缓解,但对于后者,在鼻咽部呼吸阻塞、病理性抗链球菌溶血素 O 滴度和耳部炎症病变方面缺乏成功。
本研究证实了先前随机临床研究中出现的观察结果,即对于复发性发热性咽扁桃体炎,即使在很大比例接受观察等待的对照组患者中也有可能实现有效预防;然而,这些研究也表明,与接受手术的组相比,对照组中其他症状得到缓解的受试者百分比非常低。换句话说,就患者的总体症状情况而言,手术治疗的有效性以及药物治疗在与复发性发热性炎症相关的所有临床表现中的失败显而易见。因此,有必要选择并建议最合适的治疗策略,不是根据基于统计研究结果制定的指南,由于其内在的方法学局限性,不能不加区分地应用于所有病例,而是要根据每个患者的具体临床情况。